Conference Coverage

SGLT-2 inhibitors promising for heart failure prevention, not treatment


 

EXPERT ANALYSIS FROM WCIRDC 2018

Pages

Recommended Reading

New diabetes guidelines downgrade insulin as first-line injectable treatment
MDedge Cardiology
New risk-prediction model for diabetes under development
MDedge Cardiology
Societies refresh diabetes and PAD guidance
MDedge Cardiology
‘Payoff will be great’ if we can conquer childhood obesity, expert says
MDedge Cardiology
EHRs and Burnout
MDedge Cardiology
Cerebral small vessel and cognitive impairment
MDedge Cardiology
New diabetes drugs solidify their cardiovascular and renal benefits
MDedge Cardiology
Prenatal valproate and ADHD
MDedge Cardiology
Postprandial glucose responses to identical meals vary from person to person
MDedge Cardiology
Torrent Pharmaceuticals expands losartan recall
MDedge Cardiology